Best Practice & Research Clinical Anaesthesiology
Volume 21, Issue 4 , Pages 497-516 , December 2007

Volume and electrolyte management

  • Concezione Tommasino, MD (Associate Professor of Anaesthesiology and Intensive Care)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39 02 50319016; Fax: +39 02 50319040.

References 

  1. Tommasino C. Fluid Management. In:  Newfield P,  Cottrell JE editor. Handbook of Neuroanesthesia. Fourth Edition. New York: Lippincott-Williams & Wilkins; 2007;p. 379–395
  2. Shenkin HA, Benzier HO, Bouzarth W. Restricted fluid intake: rational management of the neurosurgical patient. Journal of Neurosurgery. 1976;45:432–436
  3. Chestnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. The Journal of Trauma. 1993;34:216–222
  4. Chesnut RM. Avoidance of hypotension: condition sine qua non of successful severe head-injury management. The Journal of Trauma. 1997;42:S4–S9
  5. Pietropaoli JA, Rogers FB, Shackford SR, et al. The deleterious effects of intraoperative hypotension on outcome in patients with severe head injuries. The Journal of Trauma. 1992;33:403–407
  6. Clifton GL, Miller ER, Choi SC, et al. Fluid thresholds and outcome from severe brain injury. Critical Care Medicine. 2002;30:739–745
  7. Berkenstadt H, Margalit N, Hadani M, et al. Stroke volume variation as a predictor of fluid responsiveness in patients undergoing brain surgery. Anesthesia and Analgesia. 2001;92:984–989
  8. Hebert PC, Wells G, Blajchman MA, et al. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. The New England Journal of Medicine. 1999;340:409–417
  9. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004;292:1555–1562
  10. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. Journal of Neurosurgery. 2004;101:1–7
  11. Dutton RP, McCunn M, Hyder M, et al. Factor VIIa for correction of traumatic coagulopathy. The Journal of Trauma. 2004;57:709–719
  12. Kristensen J, Killander A, Hippe E, et al. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis. 1996;26:159–164
  13. Hawryluk GWJ, Cusimano MD. The role of recombinant activated factor VII in neurosurgery: hope or hype?. Journal of Neurosurgery. 2006;105:859–868
  14. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. The New England Journal of Medicine. 2005;352:777–785
  15. Karadimov D, Binev K, Nachkov Y, Platikanov V. Use of activated recombinant Factor VII (NovoSeven) during neurosurgery. Journal of Neurosurgical Anesthesiology. 2003;15:330–332
  16. Barletta JF, Ahrens CL, Tyburski JG, Wilson RF. A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients. The Journal of Trauma. 2005;58:646–651
  17. Pickard JD, Kirkpatrick PJ, Melsen T, et al. Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage. Blood Coagulation & Fibrinolysis. 2000;11(Supplement 1):S117–S120
  18. Robertson CS. Management of cerebral perfusion pressure after traumatic brain injury. Anesthesiology. 2001;95:1513–1517
  19. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. The Journal of Neurosurgery. 1955;83:949–962
  20. Eker C, Asgeirsson B, Grande PO, et al. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Critical Care Medicine. 1998;26:1881–1886
  21. Nordstrom CH. Physiological and biochemical principles underlying volume-targeted therapy: the Lund concept. Neurocritical Care. 2005;2:83–95
  22. Guidelines for the management of severe head injury. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Journal of Neurotrauma. 1996;13:641–734
  23. Bullock RM, Chesnut R, Clifton GL, et al. Management and prognosis of severe traumatic brain injury, part 1: Guidelines for the management of severe traumatic brain injury. Journal of Neurotrauma. 2000;17:451–553
  24. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischaemic insults after severe head injury. Critical Care Medicine. 1999;27:2086–2095
  25. Contant CF, Valadka AB, Gopinath SP, et al. Adult respiratory distress syndrome: a complication of induced hypertension after severe head injury. Journal of Neurosurgery. 2001;95:560–568
  26. Guidelines for the Management of Severe Traumatic Brain Injury 3rd Edition. Journal of Neurotrauma. 2007;24(Supplement 1):4–117
  27. Varney KL, Young B, Hatton J. Albumin use in neurosurgical critical care. Pharmacotherapy. 2003;23:88–92
  28. Starling EH. On the Absorption of fluids from the connective tissue spaces. J Physiol. 1896;19:312–326
  29. Thomas DJ, Marshall J, Russell RW, et al. Effect of haematocrit on cerebral blood-flow in man. Lancet. 1977;2:941–943
  30. Ekelund A, Reinstrup P, Ryding E, et al. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochirurgica. 2002;144:703–712
  31. Tommasino C, Moore S, Todd MM. Cerebral effects of isovolemic hemodilution with crystalloid or colloid solutions in normal rabbits. Critical Care Medicine. 1988;16:862–868
  32. Takil A, Eti Z, Irmak P, et al. Early postoperative respiratory acidosis after large intravascular volume infusion of lactated ringer's solution during major spine surgery. Anesthesia and Analgesia. 2002;95:294–298
  33. Marshall LF, Smith RW, Rauscher LA. Mannitol dose requirements in brain injured patients. Journal of Neurosurgery. 1978;48:169–172
  34. Maas AI, Dearden M, Teasdale GM, et al. EBIC-guidelines for management of severe head injury in adults: European Brain Injury Consortium. Acta Neurochirurgica. 1997;139:286–294
  35. Ranger-Castillo L, Robertson CS. Management of intracranial hypertension. Critical Care Clinics. 2006;22:713–732
  36. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol induced acute renal failure. Medicine (Baltimore). 1990;69:153–159
  37. Kofke WA. Mannitol: potential for rebound intracranial hypertension?. Journal of Neurosurgical Anesthesiology. 1993;5:1–3
  38. Palma L, Bruni G, Fiaschi AI, Mariottini A. Passage of mannitol into the brain around gliomas: a potential cause of rebound phenomenon. A study on 21 patients. Journal of Neurosurgical Sciences. 2006;50:63–66
  39. Betz AL. Sodium transport in capillaries isolated from rat brain. Journal of Neurochemistry. 1983;41:1150–1157
  40. Fenstermacher JD, Johnson JA. Filtration and reflection coefficients of the rabbit blood–brain barrier. The American Journal of Physiology. 1966;211:341–346
  41. Todd MM, Tommasino C, Moore S. Cerebral effects of isovolemic hemodilution with a hypertonic saline solution. Journal of Neurosurgery. 1985;63:944–948
  42. Wade CE, Grady JJ, Kramer GC, et al. Individual patient cohort analysis of the efficacy of hypertonic saline/dextran in patients with traumatic brain injury and hypotension. The Journal of Trauma. 1997;42:S61–S65
  43. Bentsen G, Breivik H, Lundar T, Stubhaug A. Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in critically ill patients with subarachnoid haemorrhage. Acta Anaesthesiologica Scandinavica. 2004;48:1089–1095
  44. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33:136–140
  45. Gemma M, Cozzi S, Tommasino C, et al. 7.5% hypertonic saline versus 20% mannitol during elective supratentorial procedures. Journal of Neurosurgical Anesthesiology. 1997;9:329–334
  46. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science. 1981;211:1068–1070
  47. Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Critical Care Medicine. 2000;28:1136–1143
  48. White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesthesia and Analgesia. 2006;102:1836–1846
  49. Bruegger D, Bauer A, Rehm M, et al. Effect of hypertonic saline dextran on acid-base balance in patients undergoing surgery of abdominal aortic aneurysm. Critical Care Medicine. 2005;33:556–563
  50. Trumble ER, Muizelaar JP, Myseros JS, et al. Coagulopathy with the use of hetastarch in the treatment of vasospasm. Journal of Neurosurgery. 1995;82:44–47
  51. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The U.S.A. Multicenter Trial. Annals of Surgery. 1991;213:482–491
  52. Schwarz S, Schwab S, Bertram M, et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29:1550–1555
  53. Prough DS, Bidani A. Hyperchloremic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. Anesthesiology. 1999;90:1247–1249
  54. Gottlieb A, Schoenwald P, Popovich MJ, et al. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesthesia and Analgesia. 2001;93:817–822
  55. Ribo M, Molina CA, Delgado P, et al. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. advance online publication Journal of Cerebral Blood Flow and Metabolism. 2007;9:1616–1622
  56. Martin A, Rojas S, Chamorro A, et al. Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation. Stroke. 2006;37:1288–1295
  57. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–2432
  58. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine. 2001;345:1359–1367
  59. The United Kingdom Glucose Insulin in Stroke Trial (GIST-UK) Collaborators . Glucose-potassium-insulin infusions in the management of post stroke hyperglycaemia. The United Kingdom Glucose Insulin in Stroke Trial (GIST-UK): A randomised controlled trial. Lancet Neurology. 2007;6:397–406
  60. Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Systemic Reviews. 2002;(4):CD000103
  61. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369:306–318
  62. Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 1997;349:245–249
  63. Mori K, Arai H, Nakajima K, et al. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 1995;26:1620–1626
  64. Lee KH, Lukovis T, Friedman JA. ‘Triple-H’ therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocritical Care. 2006;4:68–76
  65. Cole CD, Gottfried ON, Liu JK, Couldwell WT. Hyponatremia in the neurosurgical patient: diagnosis and management. Neurosurgical Focus. 2004;16:E9
  66. Badaut J, Lasbennes F, Magistretti PJ, Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. Journal of Cerebral Blood Flow and Metabolism. 2002;22:367–378

PII: S1521-6896(07)00075-4

doi: 10.1016/j.bpa.2007.07.002

Best Practice & Research Clinical Anaesthesiology
Volume 21, Issue 4 , Pages 497-516 , December 2007

Article Tools